At the inaugural Yangtze River Delta AI & Healthcare Innovation Conference, Suzhou First Affiliated Hospital and Surgerii Robotics were honored for their pioneering work in robotic thoracic surgery using China’s first single-port robotic system, SHURUI®.
The team has completed complex procedures—including lobectomy, segmentectomy, and bronchial sleeve resections—with 100% success, zero conversions, and outstanding outcomes. Notably, in April 2025, Prof. Jun Zhao’s team completed the world’s first cross-continental robotic lobectomy using the SHURUI® system and 5G connectivity—linking China and Romania in a real-time operation with <80ms delay.
Experts at the event praised the team’s technical leadership, noting it as a breakthrough for China’s high-end surgical technology. Looking ahead, the hospital will expand robotic research into esophageal and mediastinal surgeries, advancing AI-integrated, ultra-minimally invasive care across the region.
The SHURUI Single-port Endoscopic Surgical System (SR-ENS-600), developed and produced by Beijing Surgerii Robotics Company Limited, has obtained the CE marking for urologic laparoscopic surgical procedures, gynecologic laparoscopic surgical procedures, general laparoscopic surgical procedures, and thoracoscopic surgical procedures. It is intended for use by trained surgeons in an operating room environment in accordance with the representative, specific procedures set forth in the User Manual.
Safety and Performance Information
Beijing Surgerii Robotics Co., Ltd. owns Surgerii®, SHURUI®, and other trademarks and may not be used without permission.